155 related articles for article (PubMed ID: 21477210)
1. Myeloid-derived suppressor cells--their role in haemato-oncological malignancies and other cancers and possible implications for therapy.
Tadmor T; Attias D; Polliack A
Br J Haematol; 2011 Jun; 153(5):557-67. PubMed ID: 21477210
[TBL] [Abstract][Full Text] [Related]
2. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
Fujimura T; Mahnke K; Enk AH
J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.
Younos IH; Abe F; Talmadge JE
Leuk Lymphoma; 2015; 56(8):2251-63. PubMed ID: 25407654
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cell heterogeneity and subset definition.
Peranzoni E; Zilio S; Marigo I; Dolcetti L; Zanovello P; Mandruzzato S; Bronte V
Curr Opin Immunol; 2010 Apr; 22(2):238-44. PubMed ID: 20171075
[TBL] [Abstract][Full Text] [Related]
5. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
[TBL] [Abstract][Full Text] [Related]
6. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.
Jiang J; Guo W; Liang X
Hum Immunol; 2014 Nov; 75(11):1128-37. PubMed ID: 25305034
[TBL] [Abstract][Full Text] [Related]
7. Amino acid metabolism related to immune tolerance by MDSCs.
Yang B; Wang X; Ren X
Int Rev Immunol; 2012 Jun; 31(3):177-83. PubMed ID: 22587019
[TBL] [Abstract][Full Text] [Related]
8. Antigen specificity of immune suppression by myeloid-derived suppressor cells.
Solito S; Bronte V; Mandruzzato S
J Leukoc Biol; 2011 Jul; 90(1):31-6. PubMed ID: 21486906
[TBL] [Abstract][Full Text] [Related]
9. Contribution of myeloid-derived suppressor cells to tumor-induced immune suppression, angiogenesis, invasion and metastasis.
Ye XZ; Yu SC; Bian XW
J Genet Genomics; 2010 Jul; 37(7):423-30. PubMed ID: 20659706
[TBL] [Abstract][Full Text] [Related]
10. Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.
Haile LA; von Wasielewski R; Gamrekelashvili J; Krüger C; Bachmann O; Westendorf AM; Buer J; Liblau R; Manns MP; Korangy F; Greten TF
Gastroenterology; 2008 Sep; 135(3):871-81, 881.e1-5. PubMed ID: 18674538
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targeting of myeloid-derived suppressor cells.
Ugel S; Delpozzo F; Desantis G; Papalini F; Simonato F; Sonda N; Zilio S; Bronte V
Curr Opin Pharmacol; 2009 Aug; 9(4):470-81. PubMed ID: 19616475
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L; Marigo I; Mantelli B; Peranzoni E; Zanovello P; Bronte V
Cancer Lett; 2008 Aug; 267(2):216-25. PubMed ID: 18433992
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I; Dolcetti L; Serafini P; Zanovello P; Bronte V
Immunol Rev; 2008 Apr; 222():162-79. PubMed ID: 18364001
[TBL] [Abstract][Full Text] [Related]
14. Transcription factors in myeloid-derived suppressor cell recruitment and function.
Sonda N; Chioda M; Zilio S; Simonato F; Bronte V
Curr Opin Immunol; 2011 Apr; 23(2):279-85. PubMed ID: 21227670
[TBL] [Abstract][Full Text] [Related]
15. Putting the brakes on anticancer therapies: suppression of innate immune pathways by tumor-associated myeloid cells.
Jinushi M; Yagita H; Yoshiyama H; Tahara H
Trends Mol Med; 2013 Sep; 19(9):536-45. PubMed ID: 23810190
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells in cancer patients: a clinical perspective.
Montero AJ; Diaz-Montero CM; Kyriakopoulos CE; Bronte V; Mandruzzato S
J Immunother; 2012; 35(2):107-15. PubMed ID: 22306898
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells in cancer: recent progress and prospects.
Khaled YS; Ammori BJ; Elkord E
Immunol Cell Biol; 2013 Sep; 91(8):493-502. PubMed ID: 23797066
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.
Katoh H; Watanabe M
Mediators Inflamm; 2015; 2015():159269. PubMed ID: 26078490
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in human cancer.
Nagaraj S; Gabrilovich DI
Cancer J; 2010; 16(4):348-53. PubMed ID: 20693846
[TBL] [Abstract][Full Text] [Related]
20. Highlights on mechanisms of drugs targeting MDSCs: providing a novel perspective on cancer treatment.
Pan W; Sun Q; Wang Y; Wang J; Cao S; Ren X
Tumour Biol; 2015 May; 36(5):3159-69. PubMed ID: 25828146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
